There is evidence that breast carcinogenesis may begin early in life, perhaps even in utero [1] [2] [3] . However, very (OR 2.3; respectively). ER␣ hypermethylation was associated with family history of breast cancer (OR 6.6; (OR 3.8; respectively). Gene promoter hypermethylation was commonly found in healthy breast tissues from women without cancer, indicating that these events are frequent and early lesions. Race and family history of cancer increase the likelihood of these early events.
hypermethylation frequency increases from ductal carcinoma in situ to metastatic lesions [15] . Another gene of interest is RAR␤, a putative tumour suppressor gene that regulates differentiation and cellular growth mediated by retinoids also is found silenced by promoter hypermethylation in breast cancer cell lines [16, 17] and breast carcinoma [18] [19] [20] . Methylation of this gene was observed in 32% of benign breast samples from cancer patients, but only in 9% of similar samples from unaffected women [21] . RAR␤ hypermethylation has also been detected in ductal lavage fluid from healthy women who are BRCA1 gene mutation carriers, providing evidence that this epigenetic change may be an early event in breast tumourigenesis [22] . However [4, 8, 15, [23] [24] [25] [26] . [14, 19, 28] . All MSP products were analysed on 2% agarose gels in 1XTBE.
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The subject characteristics are shown in [36] . The occurrence of the CIMP in more than two genes in these morphologically normal tissues may emerge with the analysis of a larger number of genes.
Breast cancer death rates among AA women are 36% higher than in EA women, despite lower incidence rates [37] . Even taking stage and socio-economic factors into account, there is evidence that AA women have more aggressive tumours [38, 39] . In addition, it has been shown that the frequency of multiple hypermethylated genes is higher in tumours from AA women than in those from EA women, especially those that are oestrogen and progesterone receptor negative [40] . 
